U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261748) titled 'MENA Consensus on Poly-L-Lactic Acid (PLLA) Biostimulator Use in Aesthetic Dermatology' on Nov. 22.
Brief Summary: This study aims to develop expert consensus on the safe and effective use of poly-L-lactic acid (PLLA) biostimulators in aesthetic dermatology across the Middle East and North Africa (MENA) region. PLLA is a commonly used injectable treatment that stimulates collagen production, but most guidelines come from Western populations and do not address the unique characteristics of Fitzpatrick III-VI skin types, which are predominant in the MENA region.
The study uses a Modified Delphi method, a well-established approach for ...